Review your content's performance and reach.
Become your target audience’s go-to resource for today’s hottest topics.
Understand your clients’ strategies and the most pressing issues they are facing.
Keep a step ahead of your key competitors and benchmark against them.
USA - April 15 2018
The requirement of nonobviousness pursuant to section 103 of Title 351 is no stranger to practitioners appearing before the Patent Trial and Appeal…
USA - June 6 2017
January 2017 started with marked activity at the federal district court level in the antitrust area of pharmaceutical producthopping. In the Eastern…
Paul A. Ragusa.